Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Oct;2(5):385–388. doi: 10.1111/j.1365-2125.1975.tb00545.x

Adrenergic beta-receptor blockade in hyperthyroidism.

I Ramsay
PMCID: PMC1402613  PMID: 9126

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbab A. G., Turner P. Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia. Postgrad Med J. 1971 Jun;47(548):329–331. doi: 10.1136/pgmj.47.548.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bricaire H., Pandos Etude clinique de l'action d'un agent bêta-bloquant (LB 46) sur certaines manifestations de l'hyper et de l'hypo-thyroïdie. Presse Med. 1971 Nov 27;79(51):2301–2304. [PubMed] [Google Scholar]
  3. Buccino R. A., Spann J. F., Jr, Pool P. E., Sonnenblick E. H., Braunwald E. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest. 1967 Oct;46(10):1669–1682. doi: 10.1172/JCI105658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buckle R. M. Treatment of thyroid crisis by beta-adrenergic blockade. Acta Endocrinol (Copenh) 1968 Jan;57(1):168–176. doi: 10.1530/acta.0.0570168. [DOI] [PubMed] [Google Scholar]
  5. CANARY J. J., SCHAAF M., DUFFY B. J., Jr, KYLE L. H. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med. 1957 Sep 5;257(10):435–442. doi: 10.1056/NEJM195709052571001. [DOI] [PubMed] [Google Scholar]
  6. Cairoli V. J., Crout J. R. Role of the autonomic nervous system in the resting tachycardia of experimental hyperthyroidism. J Pharmacol Exp Ther. 1967 Oct;158(1):55–65. [PubMed] [Google Scholar]
  7. Cullhed I., Parrow A. Acute hemodynamic changes following beta-adrenergic blockade in hyperthyroidism. Acta Med Scand. 1968 Sep;184(3):235–239. doi: 10.1111/j.0954-6820.1968.tb02449.x. [DOI] [PubMed] [Google Scholar]
  8. Das G., Krieger M. Treatment of thyrotoxic storm with intravenous administration of propranolol. Ann Intern Med. 1969 May;70(5):985–988. doi: 10.7326/0003-4819-70-5-985. [DOI] [PubMed] [Google Scholar]
  9. GAFFNEY T. E., BRAUNWALD E., KAHLER R. L. Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man. N Engl J Med. 1961 Jul 6;265:16–20. doi: 10.1056/NEJM196107062650104. [DOI] [PubMed] [Google Scholar]
  10. GOLDSTEIN S., KILLIP T., 3rd CATECHOLAMINE DEPLETION IN THYROTOXICOSIS. EFFECT OF GUANETHIDINE ON CARDIOVASCULAR DYNAMICS. Circulation. 1965 Feb;31:219–227. doi: 10.1161/01.cir.31.2.219. [DOI] [PubMed] [Google Scholar]
  11. Gibberd M. G., Staffurth J. S. Oxprenolol in thyrotoxicosis. Lancet. 1973 Jan 27;1(7796):205–205. doi: 10.1016/s0140-6736(73)90038-x. [DOI] [PubMed] [Google Scholar]
  12. Grossman W., Robin N. I., Johnson L. W., Brooks H., Selenkow H. A., Dexter L. Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. Ann Intern Med. 1971 Jun;74(6):875–879. doi: 10.7326/0003-4819-74-6-875. [DOI] [PubMed] [Google Scholar]
  13. Hadden D. R., Montgomery D. A., Shanks R. G., Weaver J. A. Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet. 1968 Oct 19;2(7573):852–854. doi: 10.1016/s0140-6736(68)91003-9. [DOI] [PubMed] [Google Scholar]
  14. Howitt G., Rowlands D. J. Beta-sympathetic blockade in hyperthyroidism. Lancet. 1966 Mar 19;1(7438):628–631. doi: 10.1016/s0140-6736(66)90825-7. [DOI] [PubMed] [Google Scholar]
  15. Kofi Ekue J. M., Lowe D. C., Shanks R. G. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Br J Pharmacol. 1970 May;38(3):546–553. doi: 10.1111/j.1476-5381.1970.tb10596.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MYERS J. D., BRANNON E. S., HOLLAND B. C. A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest. 1950 Aug;29(8):1069–1077. doi: 10.1172/JCI102338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marsden C. D., Gimlette T. M., McAllister R. G., Owen D. A., Miller T. N. Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) 1968 Mar;57(3):353–362. doi: 10.1530/acta.0.0570353. [DOI] [PubMed] [Google Scholar]
  18. McDevitt D. G., Shanks R. G., Hadden D. R., Montgomery D. A., Weaver J. A. The role of the thyroid in the control of heart-rate. Lancet. 1968 May 11;1(7550):998–1000. doi: 10.1016/s0140-6736(68)91109-4. [DOI] [PubMed] [Google Scholar]
  19. McDevitt D. G., Shanks R. G. Oxprenolol in thyrotoxicosis. Lancet. 1973 May 5;1(7810):1004–1004. doi: 10.1016/s0140-6736(73)91650-4. [DOI] [PubMed] [Google Scholar]
  20. Michie W., Hammer-Hodges D. W., Pegg C. A., Orr F. G., Bewsher P. D. Beta-blockade and partial thyroidectomy for thyrotoxicosis. Lancet. 1974 May 25;1(7865):1009–1011. doi: 10.1016/s0140-6736(74)90414-0. [DOI] [PubMed] [Google Scholar]
  21. Murayama M., Goodkind M. J. Effect of thyroid hormone on the frequency-force relationship of atrial myocardium from the guinea pig. Circ Res. 1968 Dec;23(6):743–751. doi: 10.1161/01.res.23.6.743. [DOI] [PubMed] [Google Scholar]
  22. Nelson J. K., McDevitt D. G. Comparative trial of propranolol and practolol in hyperthyroidism. Br J Clin Pharmacol. 1975 Oct;2(5):411–416. doi: 10.1111/j.1365-2125.1975.tb00549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Parsons V., Jewitt D. Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgrad Med J. 1967 Dec;43(506):756–762. doi: 10.1136/pgmj.43.506.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pimstone B., Joffe B. The use and abuse of beta-adrenergic blockade in the surgery of hyperthyroidism. S Afr Med J. 1970 Sep 19;44(37):1059–1061. [PubMed] [Google Scholar]
  25. ROWLANDS D. J., HOWITT G., MARKMAN P. PROPRANOLOL (INDERAL) IN DISTURBANCES OF CARDIAC RHYTHM. Br Med J. 1965 Apr 3;1(5439):891–894. doi: 10.1136/bmj.1.5439.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ramsay I., Greer S., Bagley C. Propranolol in neurotic and thyrotoxic anxiety. Br J Psychiatry. 1973 May;122(570):555–560. doi: 10.1192/bjp.122.5.555. [DOI] [PubMed] [Google Scholar]
  27. Riddle M., Schwartz T. B. New tactics for hyperthyroidism: sympathetic blockade. Ann Intern Med. 1970 May;72(5):749–751. doi: 10.7326/0003-4819-72-5-749. [DOI] [PubMed] [Google Scholar]
  28. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]
  29. Turner P., Hill R. C. A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs. 1968 Jul-Aug;8(4):268–271. doi: 10.1002/j.1552-4604.1968.tb00104.x. [DOI] [PubMed] [Google Scholar]
  30. WURTMAN R. J., KOPIN I. J., AXELROD J. Thyroid function and the cardiac disposition of catecholamines. Endocrinology. 1963 Jul;73:63–74. doi: 10.1210/endo-73-1-63. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES